NEWS

BOS Awareness: Inclusion, Advocacy, and Equity

What would it be if all our children were born healthy …. We love our children like any other and do everything to make their lives as livable and beautiful as possible. We really want to embrace every unique trait of our loved ones, while steering clear of using terms like “dysfunction,” “impairment,” or anything…

Read More

We have stopped …

It certainly wouldn’t have escaped your notice… We have decided not use on the social medium platform ‘X’, formerly ‘Twitter’ anymore. In practice, we have stopped posting new tweets and responding to others. The existing tweets will remain accessible for information purposes. Moreover, in the news items on our website, the button to share the…

Read More

Updated Screening Guidelines

A new publication was recently published by Patel et al. 2024 on two children with Bohring-Opitz Syndrome, who are diagnosed with liver cancer. These two, together with a previously known case, are now three individuals diagnosed with hepatoblastoma described in the medical literature. Hepatoblastoma is a very rare malignant liver cancer occurring in infants and…

Read More

Interactive Visual Aid

It’s Bohring-Opitz Syndrome Awareness Day! This year we present Your Interactive Visual Aid (IVA) on the most common symptoms of Bohring-Opitz Syndrome (BOS), which have been described in the medical literature and case studies in recent years between 2006 – 2024. We also highlight treatment options noted in the important “Bohring-Opitz Syndrome” research. Although children with…

Read More

Newsletter ASXL Registry

A new update from the ASXL registry is given this month! This registry has been created to collect information about Bohring-Opitz Syndrome and ASXL related disorders in order to achieve a better understanding of these rare conditions for patients, caregivers and medical professionals. In this newsletter, the actual numbers of registered individuals were displayed. At…

Read More

Long awaited BOS publication

The long-awaited sequel to the latest publication by Bianca Russell and her team has been released: “Clinical findings in 39 individuals with Bohring–Opitz syndrome from a global patient-driven registry with implications for tumor surveillance and recurrence risk.” This follow-up to the publications in 2015 (Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing…

Read More